Carregant...

Long-term follow up study of community based patients receiving XR-NTX for Opioid Use Disorders

BACKGROUND AND OBJECTIVES: Extended-release naltrexone (XR-NTX) is FDA-approved to prevent relapse in patients with Opioid Use Disorder. However little is known about long-term use among community-based outpatients. METHODS: Retrospective chart review and long-term follow-up survey among individuals...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Addict
Autors principals: Williams, Arthur Robin, Barbieri, Vincent, Mishlen, Kaitlyn, Levin, Frances R., Nunes, Edward V., Mariani, John J., Bisaga, Adam
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5426981/
https://ncbi.nlm.nih.gov/pubmed/28328148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajad.12527
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!